THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],”Continue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) — Two common drugs that veterinarians use to kill parasites on pets could be the solution to getting rid of bed bugs. Both fluralaner and ivermectin, which are used to kill fleas and ticks on household pets, could also kill bed bugs. The newer,Continue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) – U.S. health officials will begin testing wastewater for poliovirus in select locations around the country, including possibly at sites in Michigan and Pennsylvania. The testing will happen in communities that have low polio vaccination rates or those with possible connections to New YorkContinue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report. The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brandContinue Reading
TUESDAY, Nov. 29, 2022 (HealthDay News) — People with long COVID deal with months or years of punishing fatigue, mind-numbing brain fog or a frightening fight to take each and every breath. But they can also face the skepticism of others, a new study finds — employers and doctors questioningContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) — Fungal lung infections are spreading to parts of the United States where they were once never seen — likely a result of climate change, experts say. To the average person, the term fungal infection may conjure up thoughts of athlete’s foot or toenailContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) – U.S. health officials are tracking a new COVID variant that’s a combination of two earlier Omicron subvariants. Known as XBB, this latest subvariant now represents 3.1% of new COVID cases throughout the U.S. and 5% of cases in the Northeast. Based on preliminaryContinue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports. Metformin reduced the risk of death from COVID-19 by 44% in a group of diabetics who were taking the drug when they became infectedContinue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — It’s not too late to get the latest COVID-19 booster shot. Whether it’s the bivalent vaccine from drug maker Pfizer or from Moderna, the shots offer more protection against symptomatic infection, public health officials reiterated at a White House briefing on Tuesday. However,Continue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — Even if you’ve already had COVID-19, you can still benefit from a vaccine that can help prevent another infection, a new study shows. Danish patients gained between 60% and 94% protection against reinfection, depending on the COVID variant wave, the researchers found. TheContinue Reading